CURE Pharmaceutical [OTC: CURR] Expands Highly Valuable Medication Patent Portfolio; Marketing Expansion to Mexico, Plus New Product Applications in the Multi-Billion Dollar Erectile Dysfunction Market

Innovative Medication Development & Enhancement Company. Patents for Extraction, Concentration & Processing of Specialized Medicinal Compounds. New Marketing to Mexico in Collaboration with Factoria Bogar Subsidiary. New Oral Thin Film Products for High Value Erectile Dysfunction Market. On June 3rd CURE Pharmaceutical (OTC:CURR), an innovative medication development and enhancement company,…

CURE Extends Vitamin D, Sleep and Combination CBD Products Distribution throughout Mexico

OXNARD, Jun 08, 2020 (GLOBE NEWSWIRE via COMTEX) — OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of Factoria Bogar in Guadalajara, Mexico. PMI will have access to CURE’s innovative drug delivery platform, CUREform(TM) for its…